|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.04 CNY | -1.53% |
|
-0.33% | +0.56% |
| Apr. 15 | Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 2023 | Luyan Pharma Co.,Ltd. Announces Board Appointments | CI |
Luyan Pharma Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 19,405.92 million compared to CNY 17,508.23 million a year ago. Revenue was CNY 19,462.5 million compared to CNY 17,545.4 million a year ago.
Net income was CNY 345.16 million compared to CNY 305.87 million a year ago. Basic earnings per share from continuing operations was CNY 0.89 compared to CNY 0.79 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +0.56% | 486M | |
| +19.79% | 72.09B | |
| -2.74% | 23.88B | |
| +10.76% | 8.89B | |
| +9.15% | 8.46B | |
| -17.39% | 8.29B | |
| +8.30% | 4.9B | |
| +17.69% | 4.34B | |
| -3.66% | 3.98B | |
| -2.41% | 3.89B |
LUYAN PHARMA CO.,LTD. 